Plus   Neg

Samsung Electronics Q3 Profit Climbs; Plans Capex Of KRW 35.2 Trln For FY20

South Korea's Samsung Electronics Co Ltd (SMSN.L,SSNNF.OB,SSNLF.OB) reported Thursday that its third-quarter net profit attributable to shareholders increased to 9.27 trillion Korean won from last year's 6.11 trillion won. Basic earnings per share were 1,364 won, up from 899 won a year ago.

Operating profit grew to 12.35 trillion won from 7.78 trillion won in the prior year. Operating margin was 18.4 percent.

Revenues for the quarter increased to 66.96 trillion won from last year's 62 trillion won.

Separately, Samsung announced its capital expenditure plan of approximately 35.2 trillion Korean won, aiming to increase competitiveness of key businesses.

In the capital expenditure plan, 28.9 trillion won will be in semiconductor and 4.3 trillion won in display.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
United Airlines is adding three new flights to Croatia, Greece and Iceland, which are starting to reopen to vaccinated visitors. The move would give travelers more options for summer travel by flying direct to these countries. Last month's searches on United.com for flights to Croatia, Greece and Iceland were up 61 percent. Johnson & Johnson's (JNJ) Covid-19 vaccine is expected to be back on track as early as this weekend as a decision is expected after the advisory panel meeting of the U.S. Centers for Disease Control and Prevention (CDC) slated on April 23, according to Dr. Anthony Fauci, the chief medical adviser to President Joe Biden. MK-4482, the experimental antiviral drug for COVID-19, showed promise to prevent and treat SARS-CoV-2 infection in hamster study, according to the scientists of National Institutes of Health or NIH. The drug significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection. MK-4482, delivered orally, is now in Phase 2 and 3 human clinical studies.
Follow RTT